Osperzo (Mesalazine)

Mesalazine, the active ingredient in Osperzo, is an aminosalicylate presented as a 400 mg tablet for oral use. It is employed in the management of inflammatory bowel disease, particularly ulcerative colitis, in adult patients. GNH USA supplies Osperzo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Osperzo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Osperzo is used to treat conditions within the inflammatory bowel disease spectrum, targeting colonic inflammation.

- Ulcerative colitis: helps reduce mucosal inflammation and maintain remission remission remission. - Crohn’s disease (colonic involvement): may contribute to symptom control . - Maintenance therapy: supports long‑term disease control after induction of remission. - Prophylactic management: helps  . - Pouch  . -  

The